Risk of antimicrobial resistance transfer from companion animals - Scientific guideline

This document reflects the need for a guideline on the assessment of the risk to public health from antimicrobial resistance due to antimicrobial use in companion animals.

Keywords: Antimicrobial resistance transfer from companion animals, multi-resistant bacteria, methicillin-resistant staphylococci, meticillin-resistant Staphyloccoccus pseudintermedius (MRSP), meticillin-resistant Staphylococcus aureus (MRSA)

Current effective version

Reflection paper on the risk of antimicrobial resistance transfer from companion animals

AdoptedConsultation dates: 27/01/2015 to 30/04/2015Reference Number: EMA/CVMP/AWP/401740/2013Summary:

Antimicrobials are important tools for the therapy of infectious bacterial diseases in companion animals. Loss of efficacy of antimicrobial substances can seriously compromise animal health and welfare.

Document history

Overview of comments received on 'Reflection paper on the risk of antimicrobial resistance transfer from companion animals'

Consultation dates: 27/01/2015 to 30/04/2015Reference Number: EMA/CVMP/89283/2014

Draft reflection paper on the risk of antimicrobial resistance transfer from companion animals

Draft: consultation closedConsultation dates: 21/10/2013 to 31/01/2014Reference Number: EMA/CVMP/AWP/401740/2013Summary:

Antimicrobials are important tools for the therapy of infectious bacterial diseases in companion animals. Loss of efficacy of available antimicrobial substances can seriously compromise animal health and welfare. The need for the development of new antimicrobials for the therapy of multi-resistant infections, particularly those caused by Gram-negative bacteria, has been acknowledged in human medicine. For the future a corresponding need in veterinary medicine is to be expected.